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Long non-coding RNAs (lncRNAs) are emerging as critical regulators of various biological
processes and human diseases. The mechanisms of action involve their interactions with
proteins, RNA and genomic DNA. Most lncRNAs display strong nuclear localization.
Heterogeneous nuclear ribonucleoproteins (hnRNPs) are a large family of RNA-binding
proteins that are important for multiple aspects of nucleic acid metabolism. hnRNPs are
also predominantly expressed in the nucleus. This review discusses the interactions of
lncRNAs and hnRNPs in regulating gene expression at transcriptional and post-transcriptional levels or by changing genomic structure, highlighting their involvements in glucose
and lipid metabolism, immune response, DNA damage response, and other cellular
functions. Toward the end, several techniques that are used to identify lncRNA binding
partners are summarized. There are still many questions that need to be answered in this
relatively new research area, which might provide novel targets to control the biological
outputs of cells in response to different stimuli.
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Long non-coding RNAs (lncRNAs) are RNA transcripts that do not code for protein. They are arbitrarily considered to be at least 200 nucleotides in length, on the basis of a convenient practical cut-off
in RNA puriﬁcation protocols, which distinguishes lncRNAs from short non-coding RNAs such as
microRNAs [1–3]. Both human and mouse genomes are pervasively transcribed [4–6]. Protein-coding
RNAs represent only a small fraction of the transcriptional output in higher eukaryotes. In humans,
19 000 proteins are coded for by less than 2% of the genome [7], while the vast majority is transcribed
as non-coding RNAs. lncRNAs account for most of this pervasive transcription. More and more
lncRNAs have been demonstrated to be functional molecules rather than transcriptional noise.
Recently, 19 175 potentially functional lncRNAs were identiﬁed in the human genome [8]. They are
expressed in many different cell types and tissues. They display strong cell- and tissue-speciﬁc expression, and poor conservation, at least at the primary sequence level among species. Based on the
genomic location of their genes, lncRNAs are often placed into the following categories: (1) long
intergenic non-coding RNAs (lincRNAs); (2) natural antisense transcripts; and (3) intronic lncRNAs.
lncRNAs can be detected in the nucleus, cytoplasm, or both [9]. However, they are predominantly
localized in the nucleus and are associated with chromatin [10]. These nuclear lncRNAs exert functions through their interaction with proteins, RNA or genomic DNAs. Heterogeneous nuclear ribonucleoproteins (hnRNPs) are a large family of RNA-binding proteins that are important for multiple
aspects of nucleic acid metabolism [11,12]. hnRNPs consist of one or more RNA-binding domains
including RNA recognition motifs, Arg-Gly-Gly repeats, or hnRNP K homology domains. The activity
of hnRNPs is regulated by several post-translational modiﬁcations, including phosphorylation,
SUMOylation, ubiquitination and methylation. Increasing evidence demonstrates that hnRNPs are
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involved in the development of human disease such as neurodegenerative diseases and cancer. In the review,
we discuss how the interactions between hnRNPs and lncRNAs regulate gene expression and contribute to cellular homeostasis, participating in glucose metabolism, lipid metabolism, immune response, DNA damage
response, and other cellular functions (Table 1). Based on the mechanisms of action, the interactions of lncRNAs
and hnRNPs are categorized into four groups: (1) lncRNA interacts with hnRNP to induce gene expression;
(2) lncRNA interacts with hnRNP to restrain gene expression; (3) lncRNA and hnRNP interaction controls
mRNA stability and translation; and (4) lncRNA and hnRNP interaction regulates genome structure (Figure 1).

lncRNA interacts with hnRNP to induce gene expression
The interactions of lncRNAs and hnRNPs can activate gene expression, although there are only a few examples.
lncRNA THRIL (TNFα and hnRNP L related immunoregulatory lincRNA) also known as linc1992 is one of
the lincRNAs that are differentially expressed following innate activation of THP1 macrophages [13]. THRIL
forms a complex with hnRNP L and binds to the promoter of TNFα to induce its expression. Moreover, it was
found that lincRNA-p21 acts in concert with hnRNP K as a coactivator for p53-dependent p21 transcription
[14]. lincRNA-p21 was required for the recruitment of hnRNP K and p53 to the p21 promoter [14].
In addition to lncRNA THRIL and lincRNA-p21, there are several other lncRNAs including brown fat
lncRNA-1 (Blnc1) and brown adipose tissue enriched long non-coding RNA 1 (lnc-BATE1) that can induce
gene expression through interaction with hnRNPs [15–17]. Blnc1 expression is highly induced during brown
adipocyte differentiation [16]. Blnc1 stimulates the thermogenic gene programme in brown adipocytes, and is
required for brown adipocyte differentiation [16]. Blnc1 is conserved between mice and humans, and human
Blnc1 also increases the expression of several transcriptional regulators of the thermogenic programme [17].
hnRNP U interacts with Blnc1 and facilitates the formation of a ribonucleoprotein complex that induces the
expression of thermogenic genes [17]. By comparing transcriptomes of mouse brown, inguinal white, and epididymal white fat, lnc-BATE1 was found to be a brown adipose tissue-selective lncRNA required for the establishment and maintenance of the identity and thermogenic capacity of brown adipocytes [15]. lnc-BATE1 also
interacts with hnRNP U, and both induce thermogenic gene expression and contribute to the adipogenesis of
brown adipose tissue [15].

lncRNA interacts with hnRNP to inhibit gene expression
Although the interactions of lncRNAs and hnRNPs can induce gene expression, more studies have shown that
the interactions repress gene expression. In this section, we will discuss how lncRNAs interact with hnRNPs to
repress gene expression, and how they participate in glucose metabolism, lipid metabolism, immune response,
p53 signaling and DNA damage response, and other cellular functions.
Glucose metabolism is tightly regulated in order to maintain blood glucose levels. Glycogen storage and degradation is one of the major mechanisms utilized to maintain glucose homeostasis between fasting and feeding
conditions. The role of fasting-induced lncRNA-liver glucokinase repressor (lncLGR) in regulating the hepatic
glycogen storage, along with hnRNP L, has been demonstrated by Ruan et al. [18]. Glucokinase (GCK) is one
of the key regulators that oscillate the physiological state of the liver between fasting and feeding conditions.
Over expression of lncLGR in the liver decreases GCK expression and glycogen storage while its depletion
increases GCK expression and hepatic glycogen storage [18]. Similarly, knockdown of hnRNP L increases GCK
expression at both the mRNA and protein levels. lncLGR facilitates the recruitment of hnRNP L to the
GCK promoter and subsequently suppresses transcription of GCK [18]. In a fed state, activation of hepatic GCK
activity shifts the liver from a glucose-utilizing organ to a glucose-storing organ. Fasting induces the expression
of lncLGR, which binds to hnRNP L to form a functional complex that suppresses transcription of GCK, resulting in reduced glycogen storage [18]. These data suggest that the interaction of lncLGR and hnRNP L plays an
important role in promoting glucose production from glycogen by inhibiting GCK expression during fasting. A
previous study suggested that lncRNAs with very low copy numbers are usually involved in cis-regulation of
gene expression [14]. In this study, lncLGR, with a very low copy number of 3.6 per cell, was demonstrated to
be acting in trans by promoting the recruitment of hnRNP L to the GCK promoter [18]. It remains unknown
how the lncLGR and hnRNP L complex is removed from the GCK promoter before the transition to fed state.
Cholesterol is essential for life, but higher cholesterol levels correlate with the risk of cardiovascular diseases.
Therefore, cholesterol levels in cells and blood circulation are controlled at multiple levels. The liver X receptors
(LXRs) are very important regulators of cellular and systemic cholesterol homeostasis. Activation of LXRs
increases cholesterol efﬂux, inhibits cholesterol uptake, and promotes fatty acid synthesis. lncRNA LeXis
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Table 1 The interaction of lncRNAs and hnRNPs in regulating cellular functions
lncRNAs

hnRNPs

Functions

References

lncLGR

hnRNP L

Regulation of hepatic glycogen storage

[13]

LeXis

Raly

Cholesterol level regulation, cholesterol biosynthesis gene
expression

[15]

lincRNA-Cox2

hnRNP A/B, A2/
B1

Macrophage gene expression after TLR signalling, NF-κB
coactivator

[16,17]

lincRNA-EPS

hnRNP L

Restrains the expression of immune genes

[18]

THRIL

hnRNP L

TNF-α expression

[19]

lnc13

hnRNP D

Regulation of inflammation in celiac disease patients

[20]

lincRNA-p21

hnRNP K

Induces or suppresses p53 target genes

[14,21]

lnc00672

hnRNP F,H,K

Endometrial carcinogenesis

[23]

linc-ROR

hnRNP I

Represses p53 expression, upregulation of cMyc

[24,25]

MYU

hnRNP K

CDK6 stabilization

[26]

EWSAT1

hnRNP K

Gene suppression in Ewing sarcoma

[27]

treRNA

hnRNP K

Tumor metastsis

[28]

UCA1

hnRNP A1, I

Promotes senescence in urothelial carcinoma, cell growth in
breast cancer

[30,31]

Firre

hnRNP U

Adipogenesis regulation, cross-chromosomal interaction

[32,33]

lnc-BATE1

hnRNP U

Adipogenesis of brown adipose tissue

[34]

Xist

hnRNP U

Inactivation of X-chromosome

[36]

H19

hnRNP U

Transcriptional inhibition

[37]

BC200

hnRNPv E1, E2

Elimination of BC200 transcriptional inhibition

[40]

(liver-expressed LXR-induced sequence) is the most robustly induced lncRNA in primary mouse hepatocytes in
response to LXR activation with the selective synthetic agonist GW 3965 [19]. Adenovirus-mediated overexpression of LeXis decreased serum cholesterol, but not triglycerides, in chow-fed C57BL/6 mice. The expression
of genes related to the cholesterol biosynthetic pathway was strongly downregulated in LeXis-expressing
adenovirus-transduced livers [19]. The reduction of plasma cholesterol is independent of low-density lipoprotein receptor-mediated lipoprotein clearance. By contrast, knockdown of LeXis increases serum cholesterol
levels and liver cholesterol contents, which is accompanied by increased expression of a number of cholesterol
biosynthetic genes [19]. In LeXis-deﬁcient mice, hepatic cholesterol content was markedly increased, while the
expression of sterol synthesis genes in the liver was increased in chow-fed mice but deceased in mice maintained on a Western diet [19]. From an unbiased analysis of the LeXis interactome by mass spectrometry, the
heterogeneous ribonucleoprotein Raly was identiﬁed as a binding partner of LeXis. Adenovirus-mediated
knockdown of Raly in mouse liver reduced serum cholesterol, and inhibited the cholesterol biosynthetic
pathway, effects that were independent of low-density lipoprotein receptor expression [19]. Raly knockdown also
compromised the ability of LeXis to regulate serum cholesterol levels and hepatic gene expression, suggesting that
the action of LeXis was dependent on Raly. The promoters of cholesterol biosynthetic genes were also associated
with Raly [19]. These data demonstrate an important role of LeXis in mediating the inhibition of cholesterol
biosynthesis upon LXR activation. A human ortholog of LeXis is thought to exist, but has not yet been
characterized. How LeXis recruits Raly to speciﬁc genomic locations is also an open and interesting question.
lncRNAs are important regulators of immune response. lincRNA-Cox2 is amongst the most highly induced
lncRNAs in macrophages during the innate immune response after the activation of Toll-like receptor signaling
[20]. The expression of lincRNA-Cox2 decreases or increases the expression of more than one thousand genes
[20]. Many genes related to the immune response are upregulated when lincRNA-Cox2 is silenced. HnRNP A/
B and hnRNP A2/B1 were identiﬁed as lincRNA-Cox2 binding partners. lincRNA-Cox2 is present in both the
cytosol and nucleus, and forms a complex with hnRNP A/B and A2/B1 in both compartments [20]. Many
genes repressed by lincRNA-Cox2 overlap with the genes repressed by the two hnRNP proteins. Recruitment of
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Figure 1. The mechanisms of action by which lncRNA and hnRNP interactions regulate gene expression.
(1) lncRNAs recruit hnRNPs and turn on gene transcription; for example, lincRNA-p21 binds to hnRNP K and induces p21. (2)
lncRNAs recruit hnRNPs, and their interactions restrain gene transcription; for example, lncRNA Lexis binds to Raly and inhibits
cholesterol biosynthetic genes. (3) lncRNAs, hnRNPs and mRNA form a complex that controls mRNA stability or translation; for
example, lincRoR and hnRNP I complex regulates p53 transalation. (4) lncRNAs regulate genome organization by interacting
with nuclear matrix proteins; for example, Firre binds to the nuclear matrix protein hnRNP U.

RNA Pol II to the promoters of Ccl5 and Irf7 but not Il6 was increased when lincRNA-Cox2 or the hnRNPs
were knocked down [20]. These data conﬁrm that hnRNP A/B and hnRNP A2/B1 form a complex with
lincRNA-Cox2 to restrain the transcription of a subset of immune genes. lincRNA-EPS (erythroid prosurvival)
is also one of lncRNAs that restrain the expression of immune genes [21]. Its expression is downregulated in
macrophages upon stimulation by Toll-like receptor ligands. Genetic deletion of lincRNA-EPS potentiates the
expression of immune response genes in macrophages [21]. Interestingly, many of these genes are often
clustered within speciﬁc chromosomal locations. By contrast, ectopic expression of lincRNA-EPS inhibits the
expression of a number of immune response genes [21]. lincRNA-EPS is predominantly expressed in the
nucleus and is associated with chromatin in resting macrophages. This association maintains a heterochromatic
(repressive) chromatin state at many genomic loci of immune response genes [21]. Absence of lincRNA-EPS
leads to changes in nucleosome positioning and an increase in chromatin accessibility. The authors found
lincRNA-EPS speciﬁcally interacts with hnRNP L both in vitro and in vivo [21]. Knockdown of hnRNP L recapitulates the effect of lincRNA-EPS deﬁciency on gene expression of Cxcl10, Il6, Iﬁt1, Ccl5, and increased
H3K4me3 levels at the promoters of some of these genes [21]. Importantly, lincRNA-EPS also restrains lethal
inﬂammation in mice injected with lipopolysaccharides (LPS). In the study by Atianand et al., it remains to be
fully deﬁned how lincRNA-EPS and hnRNP L localize to the genomic loci of speciﬁc genes [21]. Further
studies are needed to examine whether the interaction of lincRNA-EPS and hnRNP L participates in the regulation of immune response genes in other cell types such as B cells, T cells, and endothelial cells. The barrier
needs to be removed in response to stimuli to allow gene expression. Genetic variations of lncRNA are associated with human disease. Castellanos-Rubio et al. uncovered the signiﬁcance of a lncRNA named lnc13 in
restraining a subset of inﬂammatory genes associated with celiac disease (CeD) [22]. They demonstrated that
disease-associated single-nucleotide polymorphisms can affect lncRNA expression, and thereby the pathogenesis of human disease. Expression of lnc13 is found to be reduced in the small intestines of CeD patients [22].
lnc13 is primarily located in the nucleus, and exclusively associated with the chromatin fraction in macrophages. Its expression was signiﬁcantly reduced upon LPS stimulation. In non-treated macrophages, lnc13 is
constitutively expressed, and forms complexes with the p42 isoform of hnRNP D to recruit Hdac1 on to the
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promoters of certain inﬂammatory genes, which results in their repression. In LPS-treated macrophages, an
active NF-κB pathway elevates decapping protein 2 (Dcp2) [22]. Decapping of lnc13 by Dcp2 causes its degradation, leaving the inﬂammatory genes unrestrained and active. Dcp2 expression was also increased in biopsies
of CeD patients, which explains the reduction of lnc13. In lnc13-deﬁcient cells, hnRNP D and Hdac1 enrichment was found to be reduced at the transcription start site of lnc13 target genes [22]. Similarly, in hnRNP D
knockout cells, binding of Hdac1 to the lnc13-regulated promoters was less efﬁcient, which indicates the role of
hnRNP D in recruiting Hdac1 to lnc13-regulated promoters [22]. Wild type lnc13 binds more efﬁciently to
hnRNP D relative to disease-associated counterparts harboring the mutation due to the CeD-associated singlenucleotide polymorphism. This demonstrates that genetic variation of lnc13 results in modiﬁcations of its secondary structure that weakens its binding with hnRNP D, which interferes with its suppressive effect on inﬂammatory genes [22]. The results demonstrate the signiﬁcant role of lnc13 and hnRNP D in regulating intestinal
immune homeostasis by restraining the expression of inﬂammatory genes. NF-κB signaling is often divided
into canonical and non-canonical pathways [23,24]; however, it remains unknown how these lncRNAs speciﬁcally regulate different NF-κB pathways and target gene expression in different cell types.
lncRNAs play a key regulatory role in DNA damage and p53 transcriptional response. Many lncRNAs are
p53 transcriptional targets. One of the p53-induced lincRNAs, lincRNA-p21, mediates the transcriptional
repression of p53 in response to DNA damage, and triggers cell apoptosis [25]. lincRNA-p21 interacts with
hnRNP K, and the interaction co-represses genes in the p53 transcriptional response. lincRNA-p21 is required
to direct the binding of hnRNP K to the promoters of these repressed genes, while hnRNP K was also identiﬁed as a transcriptional coactivator of p53, promoting gene expression in response to DNA damage [26].
linc00672 is a direct transcriptional target of p53. Overexpression of linc00672 caused a signiﬁcant accumulation of cells in the G2/M phases, and reduced cell proliferation in the human endometrial carcinoma cell line
[27]. Bioinformatics and RNA-pulldown were performed to identify the binding partners of linc00672.
linc00672 binds to hnRNP F and H, and is required to recruit hnRNPs to promote p53-dependent suppression
of the LIM and SH3 protein 1. In addition to hnRNP F and H, hnRNP K was also detected at the p53 binding
site at the LIM and SH3 protein 1 promoter. These data suggest that linc00672 is an important regulator of
p53 protein-mediated gene suppression and the oncogenesis of endometrial carcinoma.
RNA-binding protein EWS and transcription factor FLI1 (EWS-FLI1) can both activate and repress genes
that are critical for cell transformation. lncRNA Ewing sarcoma-associated transcript 1 (EWSAT1) is induced
by EWS-FLI1 in bone marrow-derived mesenchymal progenitor cells that were isolated from pediatric patients
[28]. Examination of EWSAT1 expression in tumor samples revealed that EWSAT1 is an lncRNA that is upregulated in Ewing sarcoma. EWSAT1 is an important molecule that mediates repression of genes downstream of
EWS-FLI1. Using protein array, the authors found EWSAT1 binds to 22 proteins. An interaction between
hnRNP K and EWSAT1 was validated using RNA immunoprecipitation. Interestingly, 20 out of 302 genes
repressed by hnRNP K were also repressed by EWSAT1, suggesting that EWSAT1 and hnRNP K act together
to repress the expression of a subset of genes in the context of Ewing sarcoma. Since not all
EWSAT1-repressed genes were changed after hnRNP K downregulation, EWSAT1 probably represses many
genes through interaction with other proteins.

lncRNA and hnRNP interaction controls mRNA stability and
translation
lncRNAs control gene expression at not only the transcriptional but also the post-transcriptional level. In this
section, we will discuss a few lncRNAs that regulate mRNA stability and translation. lncRNA regulator of reprogramming (linc-ROR) was ﬁrst discovered in induced pluripotent stem cells. In a more recent study, linc-RoR
was identiﬁed as a negative regulator of p53 through interaction with hnRNP I [29]. hnRNP I can bind to the
internal ribosome entry site of p53 mRNA and promote its translation. The interaction of linc-RoR with
hnRNP I occurs predominantly in the cytoplasm with phosphorylated hnRNP I, which prevents or interrupts
the interaction of hnRNP I with p53 mRNA, and suppresses DNA-damage-induced p53 translation. The
expression of linc-RoR is induced by p53, thus forming a negative feedback loop. linc-RoR also aggravates
oncogenesis by enhancing c-Myc mRNA and protein levels [30]. Both c-Myc and linc-RoR expression are
up-regulated in cancer tissues. Overexpression of linc-RoR in HCT-116 cells signiﬁcantly promotes its proliferation and tumorigenesis characteristics. Conversely, linc-RoR knockout reduces the cellular c-Myc mRNA and
protein levels [30]. Further investigation of lncRNA-mediated c-Myc regulation uncovered the signiﬁcant role
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of hnRNP I and hnRNP D (also known as AUF1) in ﬁne-tuning c-Myc mRNA stability. In tumor cells,
linc-RoR facilitates the interaction between hnRNP I and c-Myc, which results in the increased stability of
c-Myc mRNA. Consequently, the interaction of linc-RoR with hnRNP I prevents the binding of hnRNP D to
c-Myc mRNA, whereas binding of hnRNP D to c-Myc mRNA results in decay of c-Myc mRNA in noncancerous cells. In this condition, linc-RoR renders speciﬁcity in regulating the stability of c-Myc mRNA by
determining its binding with hnRNP D or hnRNP I. The ﬁndings emphasize the role of lncRNAs acting as
molecular anchors that ﬁne-tune cell signaling by recruiting different types of multifunctional hnRNPs, resulting in repression or activation of speciﬁc genes. Transcription factor c-Myc plays a critical role in the development of colorectal cancer. c-Myc is known to induce the expression of an lncRNA named MYU [31]. MYU
interacts with hnRNP K to stabilize cyclin-dependent kinase 6 (CDK6) expression and thereby promote the
G1-S transition of the cell cycle. Mechanistically, MYU, hnRNP K, and CDK6 mRNA form a complex in
which hnRNP K inhibits the interaction of miR-16 with its binding site in the 30 UTR of CDK6 mRNA.
We have discussed that lncRNAs linc-RoR and MYU control mRNA stability. Next, the translation inhibition
by lncRNA-hnRNP interactions are summarized.
Human translational regulatory lncRNA (treRNA) can function as an enhancer and regulate Snail transcription in cis (the regulation of Snail depends on the site of transcription of treRNA) [32]. In lymph-node metastatic human breast cancer samples, treRNA expression is higher than in primary breast-cancer carcinoma.
Enforced expression of treRNA increases cell migration and cell invasion through Matrigel™ in non-invasive
and non-metastatic breast cancer MCF7 cells. Knockdown of endogenous treRNA suppressed tumor metastasis
in vivo. From mass spectrometry analysis, three RNA-binding proteins among the top hits were identiﬁed,
including hnRNP K, FXR1 and FXR2. HnRNP K and FXR2 indeed mediate the effect of treRNA on both
E-cadherin suppression and promotion metastasis in vivo. TreRNA expression promotes binding of the PUF60–
SF3B3 complex to hnRNP K, FXR1 and FXR2 to form a treRNA RNP complex, which suppresses translation
by binding to translation initiation factor eIF4G1 [33]. lncRNA urothelial carcinoma associated 1 (UCA1) inhibits cell proliferation and promotes senescence [34]. UCA1 binds and sequesters hnRNP A1, preventing it from
destabilizing p16INK mRNA. lncRNA UCA1 is a direct target of the complex of CAPERα (Coactivator of AP1
and Estrogen Receptor) and T-box3, mediating their effects on cell proliferation during development and
disease. By contrast, UCA1 promotes breast cancer cell growth both in vitro and in vivo [35]. The expression of
tumor suppressor p27 is suppressed by UCA1 through its interaction with hnRNP I. In addition to UCA1, an
additional 18 lncRNAs were identiﬁed in RNA immunoprecipitation assays with hnRNP I antibodies. Ectopic
expression of hnRNP I increased UCA1 RNA stability and its level. Doxorubicin, a p53 activator, induces
hnRNP I cytoplasmic localization and phosphorylation, and its interaction with UCA1. This interaction competes with hnRNP1 for p27 binding, thus preventing hnRNP I from enhancing the translation of p27, a tumor
suppressor. Brain cytoplasmic RNA 200 nucleotides (BC200 RNA) inhibit translation in human cells [36].
HnRNP E1 and hnRNP E2 were identiﬁed as binding proteins of BC200 RNA using a yeast three-hybrid
screening [37]. HnRNP E1 and E2 compete with eIF4A for binding to BC200 RNA. HnRNP E2 forms a
ternary complex with BC200 RNA and eIF4A, while the binding of hnRNP E1 to BC200 RNA causes an alteration of the RNA secondary structure. The results suggest that hnRNP E1 and E2 probably restore BC200
RNA-mediated translation inhibition through different mechanisms [37].

lncRNA and hnRNP interaction regulates genome structure
The role of lncRNAs in regulating chromatin structure and nuclear architecture has been reviewed recently
[38]. Chromosomes are organized into domains, and linearly distant genomic loci can be associated to yield
chromosome loops and interchromosomal interactions [39]. The location of a gene relative to certain chromatin domains or nuclear structures can determine its activation [40]. Emerging evidence has demonstrated
that lncRNAs participate in the regulation of nuclear architecture. For example, as a physical scaffold, lncRNA
Xist can organize a repressive chromosome compartment [38]. hnRNP U is a nuclear matrix- or
scaffold-attachment region-associated protein [41]. In a study by Hasegawa et al., depletion of hnRNP U
resulted in the detachment of Xist from the inactive X-chromosome, suggesting hnRNP U is required for Xist
RNA localization on the inactive X-chromosome [42]. The initial phase of transcription by RNA polymerase II
involves the interaction of hnRNP with actin and their association with RNA polymerase II [43]. McHugh
et al. [44] adapted an RNA antisense puriﬁcation method (reference) to purify an lncRNA complex, followed
by quantitative mass spectrometry to identify the interacting proteins. They identiﬁed 10 proteins that were
enriched for Xist relative to control non-coding RNA. These proteins include HDAC associated repressor
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protein (SHARP), hnRNP M, hnRNP U, hnRNP C, Raly, Ptbp1, Lamin B receptor and others. In addition to
hnRNP U, it was demonstrated that SHARP and Lamin B receptor are also required for Xist-mediated transcriptional silencing of the X-chromosome [44]. An lncRNA termed functional intergenic repeating RNA
element (Firre, previously referred to as linc-RAP-1) is required for proper adipogenesis [45]. Firre binds to the
nuclear matrix protein hnRNP U. This physical interaction is required for the proper focal and nuclear localization of Firre in order to maintain the multi-chromosomal nuclear interactions [46]. Firre along with hnRNP U
probably impart speciﬁcity in organizing chromatin domains and nuclear architecture [46]. In addition to the
lncRNA Firre, there are several other lncRNAs including Blnc1 [16,17], lnc-BATE1 [15], and H19 [47] that
interact with hnRNP U. It remains unknown whether lncRNAs including Blnc1, lnc-BATE1 and H19 are
involved in organizing trans-chromosomal associations and nuclear structure.

Techniques to interrogate lncRNA–protein interactions
RNA immunoprecipitation
RNA immunoprecipitation (RIP) is a technique used to detect the interaction between an individual protein
and speciﬁc RNA molecules [48]. An antibody against a speciﬁc protein is used to immunoprecipitate the
protein and associated RNAs. Then the associated RNAs including lncRNAs can be detected with real-time
PCR or RNA sequencing [49]. RIP has limitations. It can produce false-positive results that do not reﬂect in
vivo interaction, or false-negative results because the interaction cannot survive the immunoprecipitation procedures. Cross-linked RIP has been developed to address the limitation, but it also introduces caveats [50].

Chromatin isolation by RNA puriﬁcation
Chromatin isolation by RNA puriﬁcation (ChIRP) was ﬁrst described to map genome-wide lncRNA occupancy
at chromatin in 2011 [51]. Later on, it was also successfully used to identify lncRNA-binding proteins [52].
Brieﬂy, chromatin is extracted from cross-linked cells, then biotin-conjugated antisense DNA oligos that tile the
full length of lncRNA (1 probe/100 bp length of lncRNA) are added for hybridization [53]. The biotinylated
DNA probes and associated binding partners are isolated using magnetic beads. DNA and RNA are isolated
from the beads sample for sequencing, while proteins are eluted from the beads for mass spectrometry. So
ChIRP can be used to identify DNA, RNA or protein-binding partners of lncRNA. Antisense DNA probes are
conjugated with biotin at the 30 -end with 20 nucleotides in length. LncRNA Xist interacts with 81 proteins
identiﬁed by ChIRP, and hnRNP K is one of the proteins that participates in Xist-mediated gene silencing and
histone modiﬁcations [52].

Capture hybridization analysis of RNA targets and RNA afﬁnity puriﬁcation
Capture hybridization analysis of RNA targets (CHART) was initially developed to determine where lncRNAs
bind to chromatin [54]. Antisense oligonucleotides 24–25 nucleotides in length were designed where the RNA
molecule is accessible with high RNase-H sensitivity. This is different from how DNA probes are designed in
the ChIRP assay. CHART was successfully adapted to identify the proteins that are associated with lncRNAs by
using mass spectrometry [55]. RNA afﬁnity puriﬁcation (RAP) is also used to identify a lncRNA of interest
and its associated proteins using antisense biotinylated DNA oligos [56]. RAP utilizes 120-nucleotide antisense
RNA probes to form extremely strong hybrids with the target RNA for high speciﬁcity. A pool of overlapping
probes tiled across the full length of the target RNA is used for robustly capturing the endogenous lncRNA.
RAP was developed further to purify an lncRNA complex and identify the interacting protein by quantitative
mass spectrometry [44].

Psoralen analysis of RNA interactions and structures
Psoralen analysis of RNA interactions and structures (PARIS) is a method for mapping RNA duplexes on a
transcriptome-wide scale [57]. After UV-mediated psoralen crosslinking of duplex regions in cells, the isolated
cross-linked fragments are analyzed by reverse transcription and next generation DNA sequencing. Sequencing
results are mapped to the reference genome and analyzed to collect the information for RNA interactions and
structures. PARIS is a great tool to map lncRNA structures and explore its functional roles.
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RNA pulldown assay
lncRNA pulldown is a relatively easier method and is frequently used to identify various proteins that interact
with an lncRNA of interest. lncRNA molecules are generated using in vitro transcription assay. Biotin-UTP is
incorporated along the sequence of the RNA. The biotinylated lncRNA molecules are used for pulldown of its
protein-binding partners identiﬁed by mass spectrometry.

Concluding remarks and future prospects
In this review, we summarized the role of lncRNA and hnRNP interactions in regulating gene expression and
cellular functions. The mechanisms of action can mainly be categorized into the following groups: (1) lncRNAs
recruit hnRNPs and turn on gene transcription by binding to gene promoters; (2) lncRNAs recruit hnRNPs,
and their interactions at speciﬁc genomic locations restrain gene transcription; (3) lncRNAs, hnRNPs and
mRNA form a complex that controls mRNA stability or translation; and (4) lncRNAs regulate genome organization by interacting with nuclear matrix proteins, indirectly affecting gene expression (Figure 1). More and
more lncRNAs will be identiﬁed as critical regulators of biological processes and human diseases.
There are several areas that warrant further investigation. Firstly, a general framework has been proposed
that the act of transcription of lncRNAs would mark the spots for nuclear proteins such as hnRNPs to pull the
genomic DNA, thus affecting the spatial organization of the genome and transcription output [58]. How
hnRNPs contribute to the interplay between genome organization and the act of transcription of lncRNAs is
important to investigate. With new technology available to assess how genome structure inﬂuences whether
genes are switched on or off [59], the role of more and more lncRNAs in controlling gene expression by affecting genome structure will be revealed. Secondly, the function–structure relationship should be further investigated. Protein crystallization has been very important for understanding the structure–function relationship of
proteins. This reminds us that crystallization of RNA molecules or RNA–protein complexes could greatly facilitate lncRNA functional studies. Post-transcriptional modiﬁcations such as methylation at the 6 position of
adenosine (m6A) alters the stability of RNA secondary structure, thus affecting function [60]. For example, an
m6A site in the lncRNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) induces a local
change in structure and increases recognition and binding by hnRNP C [61]. These studies provide a new direction for studying how post-transcriptional modiﬁcations such as m6A regulate the structure of lncRNAs and
their interactions with protein-binding partners. Thirdly, lncRNA conservation between species warrants
further study. lncRNA conservation should be examined at different dimensions including the primary
sequence, structure, function, and expression from syntenic loci [62]. Using a protein-centric approach to
probing hnRNP-lncRNA interactions in mouse and human may help to identify functionally conserved
lncRNAs. Fourthly, the regulation of hnRNP-lncRNA interaction should be further investigated. The location
and magnitude of the interaction for a speciﬁc lncRNA and hnRNP must be regulated to accommodate the
change of gene expression and cellular function. As an example, the mechanisms that regulate the nucleocytoplasmic shuttling of hnRNP and lncRNA complexes are important to investigate. Finally, many of the
hnRNPs are important players in neurodegenerative disease [11]. lncRNAs display very high tissue-speciﬁc
expression patterns, and a large fraction of tissue-speciﬁc lncRNAs are expressed in the brain [10]. Studying
the interaction of hnRNPs and lncRNAs in neurodegenerative disease will increase our knowledge about the
pathogenesis of the disease, and provide novel therapeutic targets.
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